Tesamorelin (20mg)
Tesamorelin peptide is a synthetic analogue of growth hormone-releasing hormone (GHRH), widely studied in preclinical research for its interaction with pituitary signaling pathways and downstream metabolic processes.
Naolux Labs supplies Tesamorelin (20mg) as a research-grade lyophilized peptide compound, offering a higher-quantity option for extended laboratory and scientific research applications.
Tesamorelin is structurally derived from the full 44-amino acid sequence of endogenous GHRH, with a trans-3-hexenoic acid modification that enhances its stability. As a result, it has become one of the most studied GHRH analogues in experimental endocrinology. Furthermore, preclinical research has explored Tesamorelin’s role in stimulating growth hormone release from the anterior pituitary, making it a compound of significant interest in hormone regulation and metabolic signaling studies.
Research has also examined Tesamorelin in the context of visceral adipose tissue reduction, lipid metabolism, and body composition modulation — areas of growing interest in metabolic and endocrine research. Additionally, its interaction with IGF-1 signaling pathways has made it a subject of investigation in cellular repair and growth-related research models. Consequently, Tesamorelin represents one of the most versatile GHRH analogues available for laboratory study.
Each vial is manufactured to research-grade purity standards and third-party tested for quality verification. Store at -20°C in a dry environment and protect from light.
Product Details:
- 20mg lyophilized peptide vial
- Research-grade purity
- Third-party tested for quality verification
- Sterile laboratory-grade preparation
- Intended for laboratory research environments
Explore related peptides: Sermorelin | MOTS-c |NAD+
Research Use Only — Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
